sorbitol treatment Search Results


93
Selleck Chemicals treatments sor
Treatments Sor, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sorbitol+treatment/Sorbitol/ppr0395699-55-0-5
Average 93 stars, based on 1 article reviews
treatments sor - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

99
Thermo Fisher sugar treatment
Sugar Treatment, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sorbitol+treatment/Sucrose/pm40221846-45-29-35
Average 99 stars, based on 1 article reviews
sugar treatment - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

90
Alomone Labs sorbitol treatment
NXF1 and MTR4 knockdown, but not CRM1 inhibition, promotes FUS nuclear retention following transcriptional inhibition. ( A ) U87 cells were transfected with NXF1 siRNA for 48 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 10 um. ( B ) Quantification of cytoplasmic to nuclear FUS ratios in siCtrl and siNXF1 transfected cells. n = 19–49 cells were analyzed in each experimental condition. (** p = 0.0033, **** p < 0.0001) Mann–Whitney U -test. ( C ) U87 cells were transfected with MTR4 siRNA for 72 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 15 um. (D) Nuclear to cytoplasmic poly(A +) RNA ratios in siCtrl and siMTR4 transfected cells. n = 27–43 cells were analyzed in each experimental condition. (*** p = 0.0007, **** p < 0.0001) Mann–Whitney U -test. (E) Quantification of cytoplasmic to nuclear FUS ratio in siCtrl and siMTR4 transfected cells. n = 27–37 cells were analyzed in each experimental condition. (** p = 0.0015, *** p = 0.0001–0.0004, **** p < 0.0001) Mann–Whitney U -test. (F) U87 cells were treated with flavo (1 µM) and/or <t>leptomycin</t> <t>B</t> (LMB, 40 nM) for 4 h followed by FUS IF. Scale bars = 15 um. (G) Cytoplasmic to nuclear FUS ratios of flavo- and/or LMB-treated cells. n > 20 cells were analyzed in each experimental condition. (**** p < 0.0001) Mann–Whitney U -test.
Sorbitol Treatment, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sorbitol+treatment/Leptomycin+B/pmc09114323-232-34-42
Average 90 stars, based on 1 article reviews
sorbitol treatment - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Boston Therapeutics l-iditol dehydrogenase iddh
NXF1 and MTR4 knockdown, but not CRM1 inhibition, promotes FUS nuclear retention following transcriptional inhibition. ( A ) U87 cells were transfected with NXF1 siRNA for 48 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 10 um. ( B ) Quantification of cytoplasmic to nuclear FUS ratios in siCtrl and siNXF1 transfected cells. n = 19–49 cells were analyzed in each experimental condition. (** p = 0.0033, **** p < 0.0001) Mann–Whitney U -test. ( C ) U87 cells were transfected with MTR4 siRNA for 72 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 15 um. (D) Nuclear to cytoplasmic poly(A +) RNA ratios in siCtrl and siMTR4 transfected cells. n = 27–43 cells were analyzed in each experimental condition. (*** p = 0.0007, **** p < 0.0001) Mann–Whitney U -test. (E) Quantification of cytoplasmic to nuclear FUS ratio in siCtrl and siMTR4 transfected cells. n = 27–37 cells were analyzed in each experimental condition. (** p = 0.0015, *** p = 0.0001–0.0004, **** p < 0.0001) Mann–Whitney U -test. (F) U87 cells were treated with flavo (1 µM) and/or <t>leptomycin</t> <t>B</t> (LMB, 40 nM) for 4 h followed by FUS IF. Scale bars = 15 um. (G) Cytoplasmic to nuclear FUS ratios of flavo- and/or LMB-treated cells. n > 20 cells were analyzed in each experimental condition. (**** p < 0.0001) Mann–Whitney U -test.
L Iditol Dehydrogenase Iddh, supplied by Boston Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sorbitol+treatment/l+iditol+dehydrogenase+iddh/10__1006_slash_bijl__2001__0601-49-26-78
Average 90 stars, based on 1 article reviews
l-iditol dehydrogenase iddh - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
ICN Biomedicals d-sorbitol
NXF1 and MTR4 knockdown, but not CRM1 inhibition, promotes FUS nuclear retention following transcriptional inhibition. ( A ) U87 cells were transfected with NXF1 siRNA for 48 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 10 um. ( B ) Quantification of cytoplasmic to nuclear FUS ratios in siCtrl and siNXF1 transfected cells. n = 19–49 cells were analyzed in each experimental condition. (** p = 0.0033, **** p < 0.0001) Mann–Whitney U -test. ( C ) U87 cells were transfected with MTR4 siRNA for 72 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 15 um. (D) Nuclear to cytoplasmic poly(A +) RNA ratios in siCtrl and siMTR4 transfected cells. n = 27–43 cells were analyzed in each experimental condition. (*** p = 0.0007, **** p < 0.0001) Mann–Whitney U -test. (E) Quantification of cytoplasmic to nuclear FUS ratio in siCtrl and siMTR4 transfected cells. n = 27–37 cells were analyzed in each experimental condition. (** p = 0.0015, *** p = 0.0001–0.0004, **** p < 0.0001) Mann–Whitney U -test. (F) U87 cells were treated with flavo (1 µM) and/or <t>leptomycin</t> <t>B</t> (LMB, 40 nM) for 4 h followed by FUS IF. Scale bars = 15 um. (G) Cytoplasmic to nuclear FUS ratios of flavo- and/or LMB-treated cells. n > 20 cells were analyzed in each experimental condition. (**** p < 0.0001) Mann–Whitney U -test.
D Sorbitol, supplied by ICN Biomedicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sorbitol+treatment/d+sorbitol/pmc02890676-132-5-8
Average 90 stars, based on 1 article reviews
d-sorbitol - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
BOC Sciences sorbitol treatment
NXF1 and MTR4 knockdown, but not CRM1 inhibition, promotes FUS nuclear retention following transcriptional inhibition. ( A ) U87 cells were transfected with NXF1 siRNA for 48 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 10 um. ( B ) Quantification of cytoplasmic to nuclear FUS ratios in siCtrl and siNXF1 transfected cells. n = 19–49 cells were analyzed in each experimental condition. (** p = 0.0033, **** p < 0.0001) Mann–Whitney U -test. ( C ) U87 cells were transfected with MTR4 siRNA for 72 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 15 um. (D) Nuclear to cytoplasmic poly(A +) RNA ratios in siCtrl and siMTR4 transfected cells. n = 27–43 cells were analyzed in each experimental condition. (*** p = 0.0007, **** p < 0.0001) Mann–Whitney U -test. (E) Quantification of cytoplasmic to nuclear FUS ratio in siCtrl and siMTR4 transfected cells. n = 27–37 cells were analyzed in each experimental condition. (** p = 0.0015, *** p = 0.0001–0.0004, **** p < 0.0001) Mann–Whitney U -test. (F) U87 cells were treated with flavo (1 µM) and/or <t>leptomycin</t> <t>B</t> (LMB, 40 nM) for 4 h followed by FUS IF. Scale bars = 15 um. (G) Cytoplasmic to nuclear FUS ratios of flavo- and/or LMB-treated cells. n > 20 cells were analyzed in each experimental condition. (**** p < 0.0001) Mann–Whitney U -test.
Sorbitol Treatment, supplied by BOC Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sorbitol+treatment/Sorbitol/pmc07724001-51-24-18
Average 90 stars, based on 1 article reviews
sorbitol treatment - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
FUJIFILM d -sorbitol
NXF1 and MTR4 knockdown, but not CRM1 inhibition, promotes FUS nuclear retention following transcriptional inhibition. ( A ) U87 cells were transfected with NXF1 siRNA for 48 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 10 um. ( B ) Quantification of cytoplasmic to nuclear FUS ratios in siCtrl and siNXF1 transfected cells. n = 19–49 cells were analyzed in each experimental condition. (** p = 0.0033, **** p < 0.0001) Mann–Whitney U -test. ( C ) U87 cells were transfected with MTR4 siRNA for 72 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 15 um. (D) Nuclear to cytoplasmic poly(A +) RNA ratios in siCtrl and siMTR4 transfected cells. n = 27–43 cells were analyzed in each experimental condition. (*** p = 0.0007, **** p < 0.0001) Mann–Whitney U -test. (E) Quantification of cytoplasmic to nuclear FUS ratio in siCtrl and siMTR4 transfected cells. n = 27–37 cells were analyzed in each experimental condition. (** p = 0.0015, *** p = 0.0001–0.0004, **** p < 0.0001) Mann–Whitney U -test. (F) U87 cells were treated with flavo (1 µM) and/or <t>leptomycin</t> <t>B</t> (LMB, 40 nM) for 4 h followed by FUS IF. Scale bars = 15 um. (G) Cytoplasmic to nuclear FUS ratios of flavo- and/or LMB-treated cells. n > 20 cells were analyzed in each experimental condition. (**** p < 0.0001) Mann–Whitney U -test.
D Sorbitol, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sorbitol+treatment/benzo+a+pyrene/pmc08954220-42-9-16
Average 90 stars, based on 1 article reviews
d -sorbitol - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Pharnext Inc pxt-3003
NXF1 and MTR4 knockdown, but not CRM1 inhibition, promotes FUS nuclear retention following transcriptional inhibition. ( A ) U87 cells were transfected with NXF1 siRNA for 48 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 10 um. ( B ) Quantification of cytoplasmic to nuclear FUS ratios in siCtrl and siNXF1 transfected cells. n = 19–49 cells were analyzed in each experimental condition. (** p = 0.0033, **** p < 0.0001) Mann–Whitney U -test. ( C ) U87 cells were transfected with MTR4 siRNA for 72 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 15 um. (D) Nuclear to cytoplasmic poly(A +) RNA ratios in siCtrl and siMTR4 transfected cells. n = 27–43 cells were analyzed in each experimental condition. (*** p = 0.0007, **** p < 0.0001) Mann–Whitney U -test. (E) Quantification of cytoplasmic to nuclear FUS ratio in siCtrl and siMTR4 transfected cells. n = 27–37 cells were analyzed in each experimental condition. (** p = 0.0015, *** p = 0.0001–0.0004, **** p < 0.0001) Mann–Whitney U -test. (F) U87 cells were treated with flavo (1 µM) and/or <t>leptomycin</t> <t>B</t> (LMB, 40 nM) for 4 h followed by FUS IF. Scale bars = 15 um. (G) Cytoplasmic to nuclear FUS ratios of flavo- and/or LMB-treated cells. n > 20 cells were analyzed in each experimental condition. (**** p < 0.0001) Mann–Whitney U -test.
Pxt 3003, supplied by Pharnext Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sorbitol+treatment/pxt3003/pmc04314660-167-17-9
Average 90 stars, based on 1 article reviews
pxt-3003 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Pharnext Inc combination therapy (baclofen, naltrexone and sorbitol)
NXF1 and MTR4 knockdown, but not CRM1 inhibition, promotes FUS nuclear retention following transcriptional inhibition. ( A ) U87 cells were transfected with NXF1 siRNA for 48 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 10 um. ( B ) Quantification of cytoplasmic to nuclear FUS ratios in siCtrl and siNXF1 transfected cells. n = 19–49 cells were analyzed in each experimental condition. (** p = 0.0033, **** p < 0.0001) Mann–Whitney U -test. ( C ) U87 cells were transfected with MTR4 siRNA for 72 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 15 um. (D) Nuclear to cytoplasmic poly(A +) RNA ratios in siCtrl and siMTR4 transfected cells. n = 27–43 cells were analyzed in each experimental condition. (*** p = 0.0007, **** p < 0.0001) Mann–Whitney U -test. (E) Quantification of cytoplasmic to nuclear FUS ratio in siCtrl and siMTR4 transfected cells. n = 27–37 cells were analyzed in each experimental condition. (** p = 0.0015, *** p = 0.0001–0.0004, **** p < 0.0001) Mann–Whitney U -test. (F) U87 cells were treated with flavo (1 µM) and/or <t>leptomycin</t> <t>B</t> (LMB, 40 nM) for 4 h followed by FUS IF. Scale bars = 15 um. (G) Cytoplasmic to nuclear FUS ratios of flavo- and/or LMB-treated cells. n > 20 cells were analyzed in each experimental condition. (**** p < 0.0001) Mann–Whitney U -test.
Combination Therapy (Baclofen, Naltrexone And Sorbitol), supplied by Pharnext Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sorbitol+treatment/combination+therapy++baclofen++naltrexone+and+sorbitol+/pmc04023663-34-19-0
Average 90 stars, based on 1 article reviews
combination therapy (baclofen, naltrexone and sorbitol) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
KaNDy Therapeutics Ltd yal devi track
NXF1 and MTR4 knockdown, but not CRM1 inhibition, promotes FUS nuclear retention following transcriptional inhibition. ( A ) U87 cells were transfected with NXF1 siRNA for 48 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 10 um. ( B ) Quantification of cytoplasmic to nuclear FUS ratios in siCtrl and siNXF1 transfected cells. n = 19–49 cells were analyzed in each experimental condition. (** p = 0.0033, **** p < 0.0001) Mann–Whitney U -test. ( C ) U87 cells were transfected with MTR4 siRNA for 72 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 15 um. (D) Nuclear to cytoplasmic poly(A +) RNA ratios in siCtrl and siMTR4 transfected cells. n = 27–43 cells were analyzed in each experimental condition. (*** p = 0.0007, **** p < 0.0001) Mann–Whitney U -test. (E) Quantification of cytoplasmic to nuclear FUS ratio in siCtrl and siMTR4 transfected cells. n = 27–37 cells were analyzed in each experimental condition. (** p = 0.0015, *** p = 0.0001–0.0004, **** p < 0.0001) Mann–Whitney U -test. (F) U87 cells were treated with flavo (1 µM) and/or <t>leptomycin</t> <t>B</t> (LMB, 40 nM) for 4 h followed by FUS IF. Scale bars = 15 um. (G) Cytoplasmic to nuclear FUS ratios of flavo- and/or LMB-treated cells. n > 20 cells were analyzed in each experimental condition. (**** p < 0.0001) Mann–Whitney U -test.
Yal Devi Track, supplied by KaNDy Therapeutics Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sorbitol+treatment/yal+devi+track/10__1080_slash_14608944__2015__1019209-22-22-26
Average 90 stars, based on 1 article reviews
yal devi track - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Medeva Pharmaceuticals Inc peptide therapeutics
NXF1 and MTR4 knockdown, but not CRM1 inhibition, promotes FUS nuclear retention following transcriptional inhibition. ( A ) U87 cells were transfected with NXF1 siRNA for 48 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 10 um. ( B ) Quantification of cytoplasmic to nuclear FUS ratios in siCtrl and siNXF1 transfected cells. n = 19–49 cells were analyzed in each experimental condition. (** p = 0.0033, **** p < 0.0001) Mann–Whitney U -test. ( C ) U87 cells were transfected with MTR4 siRNA for 72 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 15 um. (D) Nuclear to cytoplasmic poly(A +) RNA ratios in siCtrl and siMTR4 transfected cells. n = 27–43 cells were analyzed in each experimental condition. (*** p = 0.0007, **** p < 0.0001) Mann–Whitney U -test. (E) Quantification of cytoplasmic to nuclear FUS ratio in siCtrl and siMTR4 transfected cells. n = 27–37 cells were analyzed in each experimental condition. (** p = 0.0015, *** p = 0.0001–0.0004, **** p < 0.0001) Mann–Whitney U -test. (F) U87 cells were treated with flavo (1 µM) and/or <t>leptomycin</t> <t>B</t> (LMB, 40 nM) for 4 h followed by FUS IF. Scale bars = 15 um. (G) Cytoplasmic to nuclear FUS ratios of flavo- and/or LMB-treated cells. n > 20 cells were analyzed in each experimental condition. (**** p < 0.0001) Mann–Whitney U -test.
Peptide Therapeutics, supplied by Medeva Pharmaceuticals Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sorbitol+treatment/peptide+therapeutics/pm11055154-196-8-11
Average 90 stars, based on 1 article reviews
peptide therapeutics - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Medeva Pharmaceuticals Inc long-acting mph compounds metadate
NXF1 and MTR4 knockdown, but not CRM1 inhibition, promotes FUS nuclear retention following transcriptional inhibition. ( A ) U87 cells were transfected with NXF1 siRNA for 48 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 10 um. ( B ) Quantification of cytoplasmic to nuclear FUS ratios in siCtrl and siNXF1 transfected cells. n = 19–49 cells were analyzed in each experimental condition. (** p = 0.0033, **** p < 0.0001) Mann–Whitney U -test. ( C ) U87 cells were transfected with MTR4 siRNA for 72 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 15 um. (D) Nuclear to cytoplasmic poly(A +) RNA ratios in siCtrl and siMTR4 transfected cells. n = 27–43 cells were analyzed in each experimental condition. (*** p = 0.0007, **** p < 0.0001) Mann–Whitney U -test. (E) Quantification of cytoplasmic to nuclear FUS ratio in siCtrl and siMTR4 transfected cells. n = 27–37 cells were analyzed in each experimental condition. (** p = 0.0015, *** p = 0.0001–0.0004, **** p < 0.0001) Mann–Whitney U -test. (F) U87 cells were treated with flavo (1 µM) and/or <t>leptomycin</t> <t>B</t> (LMB, 40 nM) for 4 h followed by FUS IF. Scale bars = 15 um. (G) Cytoplasmic to nuclear FUS ratios of flavo- and/or LMB-treated cells. n > 20 cells were analyzed in each experimental condition. (**** p < 0.0001) Mann–Whitney U -test.
Long Acting Mph Compounds Metadate, supplied by Medeva Pharmaceuticals Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sorbitol+treatment/long+acting+mph+compounds+metadate/pm16968623-47-11-36
Average 90 stars, based on 1 article reviews
long-acting mph compounds metadate - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


NXF1 and MTR4 knockdown, but not CRM1 inhibition, promotes FUS nuclear retention following transcriptional inhibition. ( A ) U87 cells were transfected with NXF1 siRNA for 48 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 10 um. ( B ) Quantification of cytoplasmic to nuclear FUS ratios in siCtrl and siNXF1 transfected cells. n = 19–49 cells were analyzed in each experimental condition. (** p = 0.0033, **** p < 0.0001) Mann–Whitney U -test. ( C ) U87 cells were transfected with MTR4 siRNA for 72 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 15 um. (D) Nuclear to cytoplasmic poly(A +) RNA ratios in siCtrl and siMTR4 transfected cells. n = 27–43 cells were analyzed in each experimental condition. (*** p = 0.0007, **** p < 0.0001) Mann–Whitney U -test. (E) Quantification of cytoplasmic to nuclear FUS ratio in siCtrl and siMTR4 transfected cells. n = 27–37 cells were analyzed in each experimental condition. (** p = 0.0015, *** p = 0.0001–0.0004, **** p < 0.0001) Mann–Whitney U -test. (F) U87 cells were treated with flavo (1 µM) and/or leptomycin B (LMB, 40 nM) for 4 h followed by FUS IF. Scale bars = 15 um. (G) Cytoplasmic to nuclear FUS ratios of flavo- and/or LMB-treated cells. n > 20 cells were analyzed in each experimental condition. (**** p < 0.0001) Mann–Whitney U -test.

Journal:

Article Title:

doi:

Figure Lengend Snippet: NXF1 and MTR4 knockdown, but not CRM1 inhibition, promotes FUS nuclear retention following transcriptional inhibition. ( A ) U87 cells were transfected with NXF1 siRNA for 48 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 10 um. ( B ) Quantification of cytoplasmic to nuclear FUS ratios in siCtrl and siNXF1 transfected cells. n = 19–49 cells were analyzed in each experimental condition. (** p = 0.0033, **** p < 0.0001) Mann–Whitney U -test. ( C ) U87 cells were transfected with MTR4 siRNA for 72 h followed by poly(A +) RNA FISH and FUS IF. NT: No treatment; FLV: Flavo treatment (1 uM) for 4 h. Scale bar = 15 um. (D) Nuclear to cytoplasmic poly(A +) RNA ratios in siCtrl and siMTR4 transfected cells. n = 27–43 cells were analyzed in each experimental condition. (*** p = 0.0007, **** p < 0.0001) Mann–Whitney U -test. (E) Quantification of cytoplasmic to nuclear FUS ratio in siCtrl and siMTR4 transfected cells. n = 27–37 cells were analyzed in each experimental condition. (** p = 0.0015, *** p = 0.0001–0.0004, **** p < 0.0001) Mann–Whitney U -test. (F) U87 cells were treated with flavo (1 µM) and/or leptomycin B (LMB, 40 nM) for 4 h followed by FUS IF. Scale bars = 15 um. (G) Cytoplasmic to nuclear FUS ratios of flavo- and/or LMB-treated cells. n > 20 cells were analyzed in each experimental condition. (**** p < 0.0001) Mann–Whitney U -test.

Article Snippet: DNA damage was induced by doxorubicin (0.5 uM) for 24 h. To induce oxidative stress, sodium arsenite (500 uM) was added to growth media for 1 h. Osmotic stress was induced by 0.4 M sorbitol treatment for 6 h. Leptomycin B (LMB, Alomone Labs cat # L-500) was diluted in growth media to final concentrations of 10 to 40 nM and incubated with U87-MG cells from 2 to 6 h depending on the specific experiment.

Techniques: Inhibition, Transfection, MANN-WHITNEY